Close medical monitoring remains important
However, besides several case reports and observational studies, no large clinical trial specifically linking GLP-1 RAs to either increased risk or protection from NAION has been published
It has not been tested or approved by the FDA and could lead to serious health consequences if used improperly
Related Peptide Research Products Tesamorelin is listed alongside several other peptide research formats within the Incline Peps range
For patients splitting doses: Mark the vial with the date of first puncture in permanent marker Count punctures if you're splitting doses inconsistently (e.g., splitting some weeks but not others) Discard at 28 days regardless of remaining volume If you see any cloudiness, color change, or particles, discard immediately even if within the 28-day window FAQ Can I split my Zepbound dose into two injections per week
de Jesus BB, Schneeberger K, Vera E, Tejera A, Harley CB, Blasco MA (2011) The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence
